Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsDividends payablesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Limitless X Holdings (LIMX) Liabilities and Shareholders Equity (2019 - 2025)

Limitless X Holdings' Liabilities and Shareholders Equity history spans 7 years, with the latest figure at $183516.0 for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 51.87% to $183516.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 206.73% increase, with the full-year FY2025 number at $183516.0, up 51.87% from a year prior.
  • Liabilities and Shareholders Equity hit $183516.0 in Q4 2025 for Limitless X Holdings, roughly flat from $183949.0 in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for LIMX hit a ceiling of $7.4 million in Q4 2022 and a floor of $91894.0 in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $1.6 million across 5 years, with a median of $307740.0 in 2023.
  • The widest YoY moves for Liabilities and Shareholders Equity: up 3203.16% in 2023, down 95.83% in 2023.
  • Tracing LIMX's Liabilities and Shareholders Equity over 5 years: stood at $2.7 million in 2021, then skyrocketed by 175.72% to $7.4 million in 2022, then tumbled by 95.83% to $307740.0 in 2023, then tumbled by 60.73% to $120836.0 in 2024, then soared by 51.87% to $183516.0 in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for LIMX at $183516.0 in Q4 2025, $183949.0 in Q3 2025, and $1.3 million in Q2 2025.